|
Princeton,
NJ -- Since the inception of the Focused Giving Program
at Johnson & Johnson in 1980, more than $38,000,000 have been
awarded to academic scientists doing basic research to advance
science and technology in the health care and medical fields.
This competitive program opens doors to new scientific developments,
as well as promotes mutually beneficial relationships between
scientists working for the Johnson & Johnson Family of Companies
and those who carry out their work at universities or research
centers.
Johnson
& Johnson is pleased to award a Focused Giving Grant to Dr.
Alexander Neimark of TRI/Princeton. This three-year grant
will support his work related to absorption of biological
fluids (blood, mucus, etc.) by fibrous materials (personal
care products, bandages, vascular grafts, etc.). This topic
is of great importance to the biomedical and personal care
industries. Rates of absorption and retention ability of fiber
products depend on specifics of biofluid rheology, primarily
viscoelasticity, which are currently poorly understood. The
objective of this work is to study adhesion and hydrodynamic
interactions of biofluids with individual fibers and different
fibrous substrates. The outcome will be a series of computational
models of biofluid absorption, retention, and flow that may
be applied to quality control and testing of advanced fibrous
products.
Dr. Neimark
received his M.S. in Mechanical Engineering (1973), Ph.D.
in Chemical Engineering (1977), and D.Sc. in Physical Chemistry
(1988) from Moscow State University. Prior to joining TRI,
he taught and conducted research at Yale University. He joined
TRI in 1996 as Principal Scientist and was promoted to Director
of Research in June of this year. His area of expertise involves
different aspects of interfacial phenomena and porous materials
engineering ranging from molecular level theories of nanocapillarity
to macroscopic models and experimental studies of fluid flow
and sorption of porous media. Dr. Neimark's research accomplishments
are reflected in over 100 publications and numerous invited
lectures at major conferences and symposiums. More information
can be found at http://www.triprinceton.org/aneimark.
Paul J.
Serbiak, Vice President, Research & Development of Johnson
& Johnson Consumer Companies, stated, "We are very pleased
to learn that our Sanpro and Wound Care businesses will benefit
from a significant new Focused Giving Grant awarded to Dr.
Neimark. This type of fundamental research creates a strong
basis for the applied development that we do."
The management
of Johnson & Johnson is very pleased with the results of this
program. According to Dr. Raymond Ruddon, Corporate Vice President
of Science & Technology, "we are achieving a significant expansion
of our own scientific capabilities and opportunities through
this network, and this cannot help but lead to more and better
health care products from Johnson & Johnson in the future."
Johnson & Johnson has $27.5 billion in sales and is the world's
most comprehensive and broadly-based manufacturer of health
care products. Johnson & Johnson, with approximately 97,800
employees and 190 operating companies in 51 countries around
the world, sells products in 175 countries.
TRI/Princeton,
founded in 1930 as Textile Research Institute, is an independent,
non-profit research institute that performs cutting-edge research
for clients in industry, government, and academia throughout
the United States and abroad. Among our 55 member companies
are Johnson & Johnson, Du Pont, 3M, Kimberly-Clark and Procter
& Gamble. TRI/Princeton's extensive facilities include laboratories
for research in fibers and film, surface chemistry, textile
science, hair mechanochemistry, modeling and characterization
of nanoporous materials and fluid flow in fibrous and porous
materials, among others. This year TRI celebrates 70 years
of excellence in research.
|
